RxDoctor Payments Data

Olga Voloshina

Nurse Practitioner · Seattle, WANPI 1265429740

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250,113 of the $279,211 with a category attached, or 89.6%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $85,731 and has fallen 55.3% since, to $38,315 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$279,211in general payments, 2019–2025

Across 390 payments — averaging $715.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$279K
  • Galderma Laboratories, L.p.$24

What the payments were for

  • Consulting fees$5,4412%
  • Speaking & faculty fees$250,11390%
  • Travel & lodging$15,1885%
  • Food & beverage$8,4693%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)389$279,188
Galderma Laboratories, L.p.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$279,211 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington →

Other nurse practitioner in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →